Patents by Inventor Emilie LALONDE

Emilie LALONDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biopsy-driven genomic signature for prostate cancer prognosis
    Patent number: 10745760
    Abstract: There is provided herein, systems, devices and methods for determining a risk of recurrence of cancer following a cancer therapy of a patient by determining genomic instability of a tumour. There is further provided systems, devices and methods for categorizing a patient into a prognostic cancer sub-group by using copy number alterations.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: August 18, 2020
    Assignees: University Health Network, Ontario Institute for Cancer Research
    Inventors: Paul Boutros, Robert G. Bristow, Emilie Lalonde
  • Biopsy-Driven Genomic Signature for Prostate Cancer Prognosis
    Publication number: 20160333421
    Abstract: There is provided herein, systems, devices and methods for determining a risk of recurrence of cancer following a cancer therapy of a patient by determining genomic instability of a tumour. There is further provided systems, devices and methods for categorizing a patient into a prognostic cancer sub-group by using copy number alterations.
    Type: Application
    Filed: January 16, 2015
    Publication date: November 17, 2016
    Inventors: Paul BOUTROS, Robert G. BRISTOW, Emilie LALONDE